![Karen Pignet-Aiach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Pignet-Aiach
Vorstandsvorsitzender bei
LYSOGENE
Profil
Karen Pignet-Aiach is the founder of Lysogene SA, serving as Chairman & Chief Executive Officer since 2019.
Ms. Pignet-Aiach is also the founder of International Rare Diseases Research Consortium.
Current jobs include Chief Executive Officer at GenAspire Srl since 2024 and Chairman & President at Lysogene Us, Inc. Former jobs include Chairman at Vestingene SAS, Chairman at Kga SAS, Director at France Biotex SAS, Independent Director at Inventiva SA, Treasurer at EURORDIS from 2010 to 2011, Treasurer at Alliance Sanfilippo from 2010 to 2011, and Member-French Ethical Review Board at Ambroise Pare Hospital.
Education includes undergraduate degrees from ESSEC Business School and Université Paris 8 Vincennes Saint-Denis.
Aktive Positionen von Karen Pignet-Aiach
| Unternehmen | Position | Beginn |
|---|---|---|
| LYSOGENE | Vorstandsvorsitzender | 09.05.2014 |
Lysogene Us, Inc. | Vorsitzender | - |
Ehemalige bekannte Positionen von Karen Pignet-Aiach
| Unternehmen | Position | Ende |
|---|---|---|
Kga SAS
 Kga SAS Financial ConglomeratesFinance Functions as an investment holding company | Vorsitzender | 18.12.2020 |
| INVENTIVA | Direktor/Vorstandsmitglied | 25.11.2018 |
Alliance Sanfilippo | Treasurer | 01.01.2011 |
EURORDIS
 EURORDIS Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit patient organization focused on rare diseases | Treasurer | 01.01.2011 |
Ambroise Pare Hospital | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Karen Pignet-Aiach
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris 8 Vincennes Saint-Denis
 Université Paris 8 Vincennes Saint-Denis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EURORDIS
EURORDIS Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit patient organization focused on rare diseases | Commercial Services |
France Biotex SAS
 France Biotex SAS Home FurnishingsConsumer Durables Manufactures mattresses and pillows | Consumer Durables |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
International Rare Diseases Research Consortium | |
Vestingene SAS | |
Lysogene Us, Inc. | |
Kga SAS
Kga SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Alliance Sanfilippo | |
Ambroise Pare Hospital |
